| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.25 | 0.1 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |